Logistic regression analysis results of the effect of unfavorable factors for CR in 190 patients, excluding those with the M3 subtype, treated according to JALSG protocols
Variable . | P . | Odds ratio . | 95% CI . |
---|---|---|---|
NPM1, wild type | <.001 | 8.434 | 2.562-27.77 |
FAB, other than M2 | .008 | 3.247 | 1.353-7.813 |
Cytogenetic, other than good risk | .039 | 5.240 | 1.091-25.16 |
NRAS, mutation | .056 | 2.667 | 0.978-7.299 |
TP53, mutation | .058 | 6.024 | 0.941-38.46 |
WBC count, more than 100 × 109/L | .090 | 2.427 | 0.872-6.757 |
FLT3, mutation | .279 | 1.719 | 0.645-4.583 |
Age, older than 60 y | .960 | 2.427 | 0.446-2.340 |
Variable . | P . | Odds ratio . | 95% CI . |
---|---|---|---|
NPM1, wild type | <.001 | 8.434 | 2.562-27.77 |
FAB, other than M2 | .008 | 3.247 | 1.353-7.813 |
Cytogenetic, other than good risk | .039 | 5.240 | 1.091-25.16 |
NRAS, mutation | .056 | 2.667 | 0.978-7.299 |
TP53, mutation | .058 | 6.024 | 0.941-38.46 |
WBC count, more than 100 × 109/L | .090 | 2.427 | 0.872-6.757 |
FLT3, mutation | .279 | 1.719 | 0.645-4.583 |
Age, older than 60 y | .960 | 2.427 | 0.446-2.340 |